Mark Tarr

Track

Insider profile

Currently holds a position at Encompass Health Corporation

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 92% 68% 82%
Transactions
17 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President, Chief Executive Officer, Director Encompass Health Corporation Dec. 29, 2016 -
Chief Operating Officer, Executive Vice President - Operations Encompass Health Corporation Feb. 24, 2011 - Dec. 29, 2016
Mark Tarr's trades of Encompass Health Corporation's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
121.50
Quantity 118,384
Value US$14,383,656
Transaction date
Proposed sale
Price
83.64
Quantity 44,976
Value US$3,761,792
Transaction date
Proposed sale
Price
71.06
Quantity 25,330
Value US$1,799,945
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-11 2026-08-10
S Sale
69,284 -13.3%
71.81
US$3,054,012 		69,284 -13.3% 71.81 US$3,054,012
2026-08-11 2026-08-10
S Sale
25,768 -1.0%
305.90
US$4,591,690 		25,768 -1.0% 305.90 US$4,591,690
2026-08-10 2026-08-10
PrS Proposed sale
82,463
95.41
US$3,311,749 		82,463 95.41 US$3,311,749
2026-02-12 2026-02-11
S Sale
213 -0.1%
113.58
US$24,193 		213 -0.1% 113.58 US$24,193
2026-02-12 2026-02-11
S Sale
87,745 -18.9%
113.09
US$9,923,082 		87,745 -18.9% 113.09 US$9,923,082
2026-02-12 2026-02-11
S Sale
6,057 -1.3%
111.89
US$677,718 		6,057 -1.3% 111.89 US$677,718
2026-02-12 2026-02-11
S Sale
10,954 -2.3%
110.92
US$1,215,018 		10,954 -2.3% 110.92 US$1,215,018
2026-02-12 2026-02-11
S Sale
15,584 -3.1%
110.07
US$1,715,331 		15,584 -3.1% 110.07 US$1,715,331
2026-02-12 2026-02-11
S Sale
13,231 -2.6%
108.80
US$1,439,533 		13,231 -2.6% 108.80 US$1,439,533
2026-02-12 2026-02-11
S Sale
16,216 -3.1%
108.03
US$1,751,814 		16,216 -3.1% 108.03 US$1,751,814
2026-02-11 2026-02-11
PrS Proposed sale
150,000
111.59
US$16,738,961 		150,000 111.59 US$16,738,961
2025-05-20 2025-05-20
PrS Proposed sale
118,384
121.50
US$14,383,656 		118,384 121.50 US$14,383,656
2025-05-20 2025-05-20
S Sale
118,290 -18.3%
121.53
US$14,375,784 		118,290 -18.3% 121.53 US$14,375,784
2025-05-20 2025-05-20
S Sale
94 -0.0%
120.94
US$11,368 		94 -0.0% 120.94 US$11,368
2024-05-01 2024-04-30
S Sale
44,976 -7.5%
83.27
US$3,745,152 		44,976 -7.5% 83.27 US$3,745,152
2024-04-30 2024-04-30
PrS Proposed sale
44,976
83.64
US$3,761,792 		44,976 83.64 US$3,761,792
2023-08-17 2023-08-16
S Sale
25,330 -4.8%
71.06
US$1,799,950 		25,330 -4.8% 71.06 US$1,799,950
2023-08-16 2023-08-16
PrS Proposed sale
25,330
71.06
US$1,799,945 		25,330 71.06 US$1,799,945
2022-08-19 2022-08-17
S Sale
20,449 -4.4%
53.25
US$1,088,909 		20,449 -4.4% 53.25 US$1,088,909
2020-05-14 2020-05-14
S Sale
26,132 -6.4%
61.92
US$1,618,093 		26,132 -6.4% 61.92 US$1,618,093
2019-05-03 2019-05-01
S Sale
23,943 -6.5%
63.23
US$1,513,916 		23,943 -6.5% 63.23 US$1,513,916
2019-05-03 2019-05-01
S Sale
43,439 -10.6%
63.74
US$2,768,802 		43,439 -10.6% 63.74 US$2,768,802